Search results
All genres
Journal Article (17)
1.
Journal Article
89 (1), pp. 161 - 172 (2020)
Estimates for energy expenditure in free-living animals using acceleration proxies: A reappraisal. Journal of Animal Ecology 2.
Journal Article
8 (Suppl. 2), pp. 23 - 28 (2016)
Hepatoprotective liposomal glycyrrhizin in alcoholic liver injury. European Journal of Integrative Medicine 3.
Journal Article
10, 39 (2015)
Draft genome sequence of Methylibium sp. strain T29, a novel fuel oxygenate-degrading bacterial isolate from Hungary. Standards in Genomic Sciences 4.
Journal Article
165 (4), pp. 482 - 487 (2012)
Flow cytometric analysis of supravesicular structures in doxorubicin-containing pegylated liposomes. Chemistry and Physics of Lipids 5.
Journal Article
117 (2), pp. 183 - 188 (2010)
A novel kynurenic acid analogue: A comparison with kynurenic acid. An in vitro electrophysiological study. Journal of Neural Transmission 6.
Journal Article
61 (4), pp. 429 - 432 (2008)
The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: Comparative studies of the effects of SZR-72 and kynurenic acid. Neuroscience Research 7.
Journal Article
82 (17-18), pp. 915 - 919 (2008)
Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate. Life Sciences 8.
Journal Article
3 (2), pp. 169 - 188 (2008)
L-kynurenine: Metabolism and mechanism of neuroprotection. Future Neurology 9.
Journal Article
76 (5), pp. 474 - 479 (2008)
The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: An in vitro study. Brain Research Bulletin 10.
Journal Article
115 (8), pp. 1087 - 1091 (2008)
The Janus-face kynurenic acid. Journal of Neural Transmission 11.
Journal Article
32 (2), pp. 302 - 308 (2008)
Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus. Neurobiology of Disease 12.
Journal Article
7, pp. 45 - 56 (2007)
Kynurenines in the central nervous system: Recent developments. Central Nervous System Agents in Medical Chemistry 13.
Journal Article
257 (1-2), pp. 221 - 239 (2007)
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Journal of the Neurological Sciences 14.
Journal Article
156 (1-2), pp. 231 - 235 (2006)
Hippocampal (CA1) activities in Wistar rats from different vendors: Fundamental differences in acute ischemia. Journal of Neuroscience Methods 15.
Journal Article
513 (1-2), pp. 75 - 80 (2005)
Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus. European Journal of Pharmacology 16.
Journal Article
18 (3), pp. 499 - 508 (2005)
Pentapeptides derived from Aβ1–42 protect neurons from the modulatory effect of Aβ fibrils: An in vitro and in vivo electrophysiological study. Neurobiology of Disease 17.
Journal Article
47, pp. 916 - 925 (2004)
Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study. Neuropharmacology